The Korea Pharmaceutical Manufacturers Association (KPMA), led by Chairman Won Hee-mok, announced on Feb. 25 that it will hold a "Korea-UK Life Sciences Webinar" jointly with the British Embassy in Korea from 4:30 p.m. on March 8.
The event will be held through ZOOM for domestic pharmaceutical bio-industry officials interested in entering the UK pharmaceutical market. Each presentation is organized in the form of a pre-recording and provides Korean subtitles, and in the subsequent question-and-answer session, speakers participate in real-time to communicate with domestic companies.
In particular, UK government officials and representatives from key organizations of the UK Biocluster will directly speak to shed light on the current status of the UK life science ecosystem and present strategies for Korean companies to enter the British market.
First, Jiansheng Du, deputy director of the British Department of International Trade (DIT), is scheduled to explain the "British biopharmaceutical sector," and Ivana Poparic, head of Med City Cluster Development Project, will present the "Medicity and Life Science Ecosystem." Finally, Kasia Averall, director in charge of cell and gene therapy catapult, plans to introduce "cell and gene therapy catapult."
An association official said, "This webinar is designed to herald the current status of the UK life science industry and industrial promotion institutions in Korea and secure opportunities for more domestic companies to enter the UK market. We hope it will be an opportunity for Korean companies to strategically collaborate with excellent universities, research institutes, and life science companies of the UK."
